Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$37.61 - $45.72 $64,538 - $78,455
1,716 New
1,716 $68,000
Q3 2020

Nov 12, 2020

SELL
$26.38 - $33.1 $268,680 - $337,123
-10,185 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$29.93 - $50.1 $27,834 - $46,593
930 Added 10.05%
10,185 $329,000
Q1 2020

May 12, 2020

SELL
$30.35 - $67.14 $27,011 - $59,754
-890 Reduced 8.77%
9,255 $377,000
Q4 2019

Feb 14, 2020

BUY
$55.65 - $79.83 $161,106 - $231,107
2,895 Added 39.93%
10,145 $626,000
Q3 2019

Nov 06, 2019

SELL
$64.7 - $85.39 $365,231 - $482,026
-5,645 Reduced 43.78%
7,250 $528,000
Q2 2019

Jul 26, 2019

BUY
$67.77 - $82.2 $873,894 - $1.06 Million
12,895 New
12,895 $1.06 Million

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $982M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Systematic Financial Management LP Portfolio

Follow Systematic Financial Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Systematic Financial Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Systematic Financial Management LP with notifications on news.